End Cash: The amount of cash held by the company for the given period.
Aktis Oncology, Inc. (AKTS) had End Cash of $38.93M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.50M |
|
$-63.73M |
|
-- |
|
$6.50M |
|
$81.18M |
|
$-74.68M |
|
$10.95M |
|
$-63.73M |
|
$-63.73M |
|
$-63.73M |
|
$-63.73M |
|
$-63.73M |
|
$-63.73M |
|
$-74.68M |
|
$-76.98M |
|
0.81M |
|
0.81M |
|
$-78.34 |
|
$-78.34 |
|
| Balance Sheet Financials | |
$230.31M |
|
$14.60M |
|
$34.58M |
|
$264.88M |
|
$31.24M |
|
-- |
|
$46.39M |
|
$77.62M |
|
$-146.15M |
|
$187.26M |
|
$187.26M |
|
0.92M |
|
| Cash Flow Statement Financials | |
$-64.13M |
|
$65.96M |
|
$-1.21M |
|
$38.31M |
|
|
End Cash |
$38.93M |
$0.62M |
|
$5.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1149.52% |
|
-1149.52% |
|
-1184.84% |
|
-980.93% |
|
-980.93% |
|
$-73.71M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
43.61% |
|
-34.03% |
|
-24.06% |
|
-34.03% |
|
$204.66 |
|
$-90.61 |
|
$-78.83 |
|